Gabriela Canalli Kretzschmar

Dr. Gabriela Canalli Kretzschmar

Pelé Pequeno Príncipe Research Institute, Curitiba, Paraná, Brazil
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 April 2021 in Frontiers in Molecular Biosciences
Verified
Journal Article
Open access
Gabriela Canalli KretzschmarGabriela Canalli Kretzschmar
Gabriela Canalli Kretzschmar
Valéria Bumiller-Bini HochValéria Bumiller-Bini Hoch
Valéria Bumiller-Bini Hoch
MFMiguel Angelo Gasparetto Filho
Miguel Angelo Gasparetto Filho
YZYohan Ricci Zonta
Yohan Ricci Zonta
KYKaio Shu Tsyr Yu
Kaio Shu Tsyr Yu
ABAngelica Beate Winter Boldt
Angelica Beate Winter Boldt
Complement system (CS) components are associated with Alzheimer’s disease (AD), the commonest cause of dementia in the world. Neutrophils can be attracted to amyloid-β plaques by several pro-inflammatory factors, including the complement anaphylatoxin C5a. They may release neutrophil extracellular traps (NETs), which are chromatin nets associated with myeloperoxidase, elastase, and other enzymes. Some CS molecules, such as C5a, C1q, and CR1, are associated with increased neutrophil recruitment and NETs release. However, the relationship between CS molecules and NETs in AD is poorly understood. In this work, we detected higher NET concentrations in plasma and serum of Brazilian AD patients, than in elderly controls (medians = 2.78 [2.07–6.19] vs. 2.23 [0.33–4.14] ng/mL,p= 0.0005). We discussed these results within the context of our former findings on complement and AD and the context of the literature on complement and NET release, suggesting both as possible therapeutic targets to prevent the progress of the disease.

1 January 2021 in Genetics and Molecular Biology
Verified
Journal Article
Open access
PDF file
Valéria Bumiller-Bini HochValéria Bumiller-Bini Hoch
Valéria Bumiller-Bini Hoch
COCamila Oliveira-Toré
Camila Oliveira-Toré
TCTamyres Mingorance Carvalho
Tamyres Mingorance Carvalho
Gabriela Canalli KretzschmarGabriela Canalli Kretzschmar
Gabriela Canalli Kretzschmar
LGLetícia Boslooper Gonçalves
Letícia Boslooper Gonçalves
ABAngelica Beate Winter Boldt
Angelica Beate Winter Boldt
Components of the complement system and atypical parameters of coagulation were reported in COVID-19 patients, as well as the exacerbation of the inflammation and coagulation activity. Mannose binding lectin (MBL)- associated serine proteases (MASPs) play an important role in viral recognition and subsequent activation of the lectin pathway of the complement system and blood coagulation, connecting both processes. Genetic variants of MASP1 and MASP2 genes are further associated with different levels and functional efficiency of their encoded proteins, modulating susceptibility and severity to diseases. Our review highlights the possible role of MASPs in SARS-COV-2 binding and activation of the lectin pathway and blood coagulation cascades, as well as their associations with comorbidities of COVID-19. MASP-1 and/or MASP-2 present an increased expression in patients with COVID-19 risk factors: diabetes, arterial hypertension and cardiovascular disease, chronic kidney disease, chronic obstructive pulmonary disease, and cerebrovascular disease. Based also on the positive results of COVID-19 patients with anti-MASP-2 antibody, we propose the use of MASPs as a possible biomarker of the progression of COVID-19 and the investigation of new treatment strategies taking into consideration the dual role of MASPs, including MASP inhibitors as promising therapeutic targets against COVID-19.

9 August 2018 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
Gabriela Canalli KretzschmarGabriela Canalli Kretzschmar
Gabriela Canalli Kretzschmar
LOLuana Caroline Oliveira
Luana Caroline Oliveira
RNRenato Mitsunori Nisihara
Renato Mitsunori Nisihara
Thirumalaisamy P. VelavanThirumalaisamy P. Velavan
Thirumalaisamy P. Velavan
SSSérvio Túlio Stinghen
Sérvio Túlio Stinghen
ABAngelica Beate Winter Boldt
Angelica Beate Winter Boldt
Pathophysiological mechanisms are still incompletely understood for leprosy, an urgent public health issue in Brazil. Complement receptor 1 (CR1) binds complement fragments C3b/C4b deposited on mycobacteria, mediating its entrance in macrophages. We investigated CR1 polymorphisms, gene expression and soluble CR1 levels in a case-control study with Brazilian leprosy patients, aiming to understand the role of this receptor in differential susceptibility to the disease. Nine polymorphisms were haplotyped by multiplex PCR-SSP in 213 leprosy patients (47% multibacillary) and 297 controls. mRNA levels were measured by qPCR and sCR1 by ELISA, in up to 80 samples. Individuals with the most common recombinant haplotype harboring rs3849266*T in intron 21 and rs3737002*T in exon 26 (encoding p.1408Met of the York Yka+ antigen), presented twice higher susceptibility to leprosy (OR = 2.43, p = 0.017). Paucibacillary patients with these variants presented lower sCR1 levels, thus reducing the anti-inflammatory response (p = 0.040 and p = 0.046, respectively). Furthermore, the most ancient haplotype increased susceptibility to the multibacillary clinical form (OR = 3.04, p = 0.01) and presented the intronic rs12034383*G allele, which was associated with higher gene expression (p = 0.043), probably increasing internalization of the parasite. Furthermore, there was an inverse correlation between the levels of sCR1 and mannose-binding lectin (initiator molecule of the lectin pathway of complement, recognized by CR1) (R = -0.52, p = 0.007). The results lead us to suggest a regulatory role for CR1 polymorphisms on mRNA and sCR1 levels, with haplotype-specific effects increasing susceptibility to leprosy, probably by enhancing parasite phagocytosis and inflammation. The reasons for which some individuals resist Mycobacteria leprae infection, whereas others contract leprosy and only a subgroup of them become severely affected, are still poorly understood. The complement receptor 1 (CR1) serves as a gate for bacterial entry in macrophages, but its importance in the spread of infection and emergence of symptoms is unknown. Despite having many common structural and regulatory variants, the CR1 gene was investigated only once in a leprosy association study in Malawi. In order to fill in this gap, we investigated if CR1 polymorphisms are co-responsible for differential disease susceptibility in 213 leprosy patients and 297 controls, also measuring mRNA and soluble CR1 levels. Associations were dependent on specific combinations of variants in regulatory and coding regions, which were also associated with gene and protein expression. Thus, this study corroborates the importance of the CR1 receptor in the susceptibility to leprosy and is the first to bring information about CR1 polymorphisms in the Brazilian population, as well as to show the relationship between genotypes and mRNA and sCR1 levels.

22 November 2019 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
LOLuana Caroline Oliveira
Luana Caroline Oliveira
Gabriela Canalli KretzschmarGabriela Canalli Kretzschmar
Gabriela Canalli Kretzschmar
ASAndressa Cristina Moraes dos Santos
Andressa Cristina Moraes dos Santos
CCCarolina Maciel Camargo
Carolina Maciel Camargo
RNRenato Mitsunori Nisihara
Renato Mitsunori Nisihara
ABAngelica Beate Winter Boldt
Angelica Beate Winter Boldt
Pemphigus foliaceus is an autoimmune disease that is sporadic around the world but endemic in Brazil, where it is known as fogo selvagem (FS). Characterized by autoantibodies against the desmosomal cadherin desmoglein 1, FS causes painful erosions, and crusts that may be widespread. The recognition of antigens, including exposed sugar moieties, activates the complement system. Complement receptor 1 (CR1, CD35), which is responsible for the Knops blood group on erythrocytes (York and McCoy antigens), is also expressed by antigen-presenting cells. This regulates the complement system by removing opsonized antigens, blocking the final steps of the complement cascade. Membrane-bound CR1 also fosters antigen presentation to B cells, whereas soluble CR1 has anti-inflammatory properties. CR1 gene polymorphisms have been associated with susceptibility to complex diseases. In order to investigate the association of CR1 polymorphisms with FS susceptibility, we developed a multiplex sequence-specific assay to haplotype eleven polymorphisms in up to 367 FS patients and 242 controls from an endemic area and 289 from a non-endemic area. We also measured soluble CR1 (sCR1) in the serum of 53 FS patients and 27 controls and mRNA levels in the peripheral blood mononuclear cells of 63 genotyped controls. The haplotypes CR1*3B2B (with the York antigen–encoded by p.1408Met) and CR1*3A2A (with p.1208Arg) were associated with protection against FS (OR = 0.57, P = 0.027, and OR = 0.46, P = 0.014, respectively). In contrast, the CR1*1 haplotype (with the McCoy antigen – encoded by p.1590Glu) was associated with FS susceptibility (OR = 4.97, P < 0.001). Heterozygote rs12034383*A/G individuals presented higher mRNA expression than homozygotes with the G allele (P = 0.04). The lowest sCR1 levels occurred in patients with active disease before treatment (P = 0.036). Patients in remission had higher levels of sCR1 than did healthy controls (P = 0.013). Among those under treatment, patients with localized lesions also presented higher sCR1 levels than those with generalized lesions (P = 0.0073). In conclusion, the Knops blood group seems to modulate susceptibility to the disease. Furthermore, corticosteroid treatment might increase sCR1 serum levels, and higher levels may play an anti-inflammatory role in patients with FS, limiting the distribution of lesions. Based on these results, we suggest CR1 as a potential new therapeutic target for the treatment of FS.

15 September 2023 in Genes
Verified
Journal Article
Open access
PDF file
KKKathleen Liedtke Kolb
Kathleen Liedtke Kolb
AMAna Luiza Sprotte Mira
Ana Luiza Sprotte Mira
EAEduardo Delabio Auer
Eduardo Delabio Auer
IBIsabela Dall’oglio Bucco
Isabela Dall’oglio Bucco
CSCarla Eduarda de Lima e Silva
Carla Eduarda de Lima e Silva
ABAngelica Beate Winter Boldt
Angelica Beate Winter Boldt
The regulation of the hypothalamic-pituitary-adrenal (HPA) axis is associated with polymorphisms and the methylation degree of the glucocorticoid receptor gene (NR3C1) and is potentially involved in the development of metabolic syndrome (MetS). In order to evaluate the association between MetS with the polymorphisms, methylation, and gene expression of the NR3C1 in the genetically isolated Brazilian Mennonite population, we genotyped 20 NR3C1 polymorphisms in 74 affected (MetS) and 138 unaffected individuals without affected first-degree relatives (Co), using exome sequencing, as well as five variants from non-exonic regions, in 70 MetS and 166 Co, using mass spectrometry. The methylation levels of 11 1F CpG sites were quantified using pyrosequencing (66 MetS and 141 Co), and the NR3C1 expression was evaluated via RT-qPCR (14 MetS and 25 Co). Age, physical activity, and family environment during childhood were associated with MetS. Susceptibility to MetS, independent of these factors, was associated with homozygosity for rs10482605*C (OR = 4.74, pcorr = 0.024) and the haplotype containing TTCGTTGATT (rs3806855*T_ rs3806854*T_rs10482605*C_rs10482614*G_rs6188*T_rs258813*T_rs33944801*G_rs34176759*A_rs17209258*T_rs6196*T, OR = 4.74, pcorr = 0.048), as well as for the CCT haplotype (rs41423247*C_ rs6877893*C_rs258763*T), OR = 6.02, pcorr = 0.030), but not to the differences in methylation or gene expression. Thus, NR3C1 polymorphisms seem to modulate the susceptibility to MetS in Mennonites, independently of lifestyle and early childhood events, and their role seems to be unrelated to DNA methylation and gene expression.

11 February 2021 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
ABAngelica Beate Winter Boldt
Angelica Beate Winter Boldt
COCamila de Freitas Oliveira-Toré
Camila de Freitas Oliveira-Toré
Gabriela Canalli KretzschmarGabriela Canalli Kretzschmar
Gabriela Canalli Kretzschmar
HMHellen Weinschutz Mendes
Hellen Weinschutz Mendes
SSSérvio Túlio Stinghen
Sérvio Túlio Stinghen
IMIara José Taborda de Messias-Reason
Iara José Taborda de Messias-Reason
Thousands of leprosy patients not only suffer from physical deformities, but also either have or have had hepatitis B virus (HBV) coinfection. Polymorphisms of the complement system modulate susceptibility to leprosy, but genetic susceptibility to past or present HBV infection is unknown. We used sequencing and multiplex sequence-specific PCR to genotype 72 polymorphisms of seven genes (MBL2,FCN1, FCN2, FCN3, MASP1, MASP2, C3) encoding components of the lectin pathway, and two genes encoding complement receptors (CR1, VSIG4) in 190 patients, of which 74 were positive for HBsAg and/or anti-HBc (HBV+, 93.2% with a resolved infection) and 116 lepromatous patients, and 408 HBV-blood donors. In addition, we tested for levels of proteins of the lectin pathway. We found no difference between serum concentrations of mannan-binding lectin (MBL), MBL-associated serine proteins (MASP-1, MASP-2, MASP-3, MAp44), ficolin-3 (FCN-3), soluble complement receptor 1 (sCR1) and MBL mediated C4 activation, measured by ELISA or TRIFMA in up to 167 HBV+ and HBV− patients. Haplotypes lowering protein levels or encoding dysfunctional proteins increased susceptibility to HBV infection:MBL2*LYQC(OR = 3.4, p = 0.02),MASP1*AC_CC(OR = 4.0, p = 0.015) andMASP2*1C2-l(OR = 5.4, p = 0.03). Conversely,FCN1*3C2haplotype, associated with higher gene expression, was protective (OR = 0.56, P = 0.033). Other haplotypes associated with HBV susceptibility were:MASP2*2B1-i(OR = 19.25, P = 0.003),CR1*3A(OR = 2.65, P = 0.011) andVSIG4*TGGRCG(OR = 12.55, P = 0.014). Some polymorphisms in ficolin genes associated with lower protein levels increased susceptibility to leprosy/HBV infection:FCN*1(OR = 1.66, P = 0.029),FCN2*GGGCAC(OR = 6.73, P = 0.008), andFCN3*del_del_C(OR = 12.54, P = 0.037), and to lepromatous disease/HBV infection:FCN2*TA(OR = 2.5, P = 0.009), whereasFCN2*MAGwas associated with increased FCN-2 expression and resistance against coinfection (OR = 0.29, P = 0.026). These associations were independent of demographic factors and did not increase susceptibility to leprosyper se, exceptMASP2*1C2-l. Associations forFCN2, FCN3, MASP1, MASP2, andVSIG4variants were also independent of each other. In conclusion, polymorphisms compromising activation of the lectin pathway of complement increase susceptibility to HBV infection, with ficolin polymorphisms playing a major role in modulating the susceptibility among leprosy patients.